Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

Selective MMP-3 inhibitor as a candidate therapeutic for chronic dermal wounds

July 10, 2003

Amgen/Wyeth seek approval for fifth indication for anti-TNF therapy

July 9, 2003

GSK develops new glucocorticoid receptor agonists

July 9, 2003

Novel vitamin D analogues with utility in dermatological disorders designed at Galderma

July 8, 2003

Connetics submits NDA for Extina in seborrheic dermatitis

July 7, 2003

Liarozole granted E.U. orphan drug designation for congenital ichthyosis

July 4, 2003

Olux cleared for marketing in U.K.

July 3, 2003

Positive outcome for phase II study of Periostat as adjunctive treatment for rosacea

July 3, 2003

Phase II findings for onercept in psoriasis and psoriatic arthritis

June 30, 2003

Enbrel improves plaque psoriasis symptoms in phase III study

June 27, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...